how long will semaglutide be on the shortage list compounded deadline As of February 21, 2025, FDA updated its drug list, marking the injection shortage as resolved. Semaglutide injections are no longer classified as “currently in shortage,” and GLP-1 No Longer on FDA's

Top 9 Providers of Compounding Tirzepatide for 2026: A Detailed Comparison 1

GLP-1 supplies are not guaranteed to be available at a patients pharmacy of choice and the medication may not be covered by insurance

Quality active ingredients/raw materials (from FDA registered facilities) State of the art technology allowing us to replicate our process Consistent/Quality products Potency testing Complete USP 71 and USP 85 compliant testing on all sterile products compounded in our lab

Hydrophilic compounds, including peptides and proteins, are stabilized within the liposome's aqueous core, ensuring protection from enzymatic or chemical degradation